Brintellix and Brilinta Medication Errors due to Name Confusion

Project Title Brintellix and Brilinta Medication Errors due to Name Confusion
Date Posted
Sunday, March 24, 2019
Project ID
cder_mpl1r_wp017
Status
Complete
Deliverables
Sentinel Modular Program Report: Brintellix and Brilinta Medication Errors due to Name Confusion, Report 1
Sentinel Modular Program Report: Brintellix and Brilinta Medication Errors due to Name Confusion, Report 2
Sentinel Modular Program Report: Brintellix and Brilinta Medication Errors due to Name Confusion, Report 3
Related Links
2018 ICPE Symposium: Advances in the Study of Medication Errors in Computerized Healthcare Databases and Spontaneous Reporting Systems in Europe and North America
2017 ICPE Presentation: Identification of Name Confusion Medication Errors in the US FDA's Sentinel System
Prevalent Dispensings of Ticagrelor (Brilinta) and Vortioxetine Hydrobromide (Brintellix)
Identification of Potential Drug Name Confusion Errors in the Sentinel System
Description

The goal of this request is to identify medication errors due to look-a-like and sound-a-like name confusion of Brintellix and Brilinta. This request contains three reports:

  • Report 1 contains estimated numbers of Brintellix users and Brilinta users. Users with the appropriate on-label indication were evaluated, in addition to users without the appropriate on-label indication and with an on-label indication for the other drug of interest.
  • Report 2 contains estimates of Brintellix and Brilinta users with on- or off-label indications for each drug.
  • Report 3 contains estimates of Brilinta users that have a subsequent Brintellix dispensing and numbers of Brintellix users that have a subsequent Brilinta dispensing.

Data from September 30, 2013 to September 30, 2015 from 16 Data Partners contributing to the Sentinel Distributed Database (SDD) were included in this report. This request was distributed to Data Partners on August 30, 2016.

Medical Product
Brilinta
Brintellix
Health Outcome
medication error
Time Period
September 30, 2013 - September 30, 2015
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Sentinel Distributed Database (SDD)
FDA Center
CDER
Scroll to Top